Fresh off first FDA approval, Amicus spends $100M to acquire 10 gene therapies
The company acquired 10 AAV-based gene therapies in development for lysosomal storage disorders, including two already in early clinical trials.
Akouos scores $50M Series A for gene therapy in hearing loss
The Boston-based startup hopes to advance its products into clinical trials in the next 2-3 years, CEO says.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
MedImmune, 4D Molecular Therapeutics to collaborate on gene therapy
AstraZeneca subsidiary and California-based firm to develop AAV-based therapy for chronic lung disease.